Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N. Han

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Journal of Thoracic Oncology

English

Protein Kinase C Regulates Late Cell Cycle-Dependent Gene Expression

Molecular and Cellular Biology

Cell Biology

Molecular Biology

2012

English

Related publications

Apatinib Monotherapy as a Second-Line Treatment for Patients With Advanced Biliary Tract Cancer: A Retrospective Single-Center Observational Study

2019

English

A Multi-Center Phase II Study and Biomarker Analysis of Combined Cetuximab and Modified FOLFIRI as Second-Line Treatment in Patients With Metastatic Gastric Cancer

English

P109 Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients With Sensitive Relapsed SCLC

Journal of Thoracic Oncology

English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer

Cancer Research

Oncology

2018

English

P1.12-03 a Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed From Two or More Lines of Chemotherapy

Journal of Thoracic Oncology

English

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer

Cancer Research

Oncology

2007

English

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

British Journal of Cancer

Cancer Research

Oncology

2006

English

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N. Han

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Protein Kinase C Regulates Late Cell Cycle-Dependent Gene Expression

Related publications

Apatinib Monotherapy as a Second-Line Treatment for Patients With Advanced Biliary Tract Cancer: A Retrospective Single-Center Observational Study

A Multi-Center Phase II Study and Biomarker Analysis of Combined Cetuximab and Modified FOLFIRI as Second-Line Treatment in Patients With Metastatic Gastric Cancer

P109 Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients With Sensitive Relapsed SCLC

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

P1.12-03 a Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed From Two or More Lines of Chemotherapy

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)